David B. Hall

7.5k citations

58 papers · 5.0k indexed · 3 hit papers · h-index 31

Impact in

Virology top 0.5%
- HIV Research and Treatment
Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in

Virology 22
- HIV Research and Treatment 22
Chemical Health and Safety 1

Co-authors: John M. Torkelson Lynna M. Lesko Patrick T. Underhill Ulrich Meier Ingo W. Husstedt Stephane Pollentier Hans‐Christoph Diener Peter J. Goadsby
Journals: AIDS (7 papers)AIAA Journal (3 papers)Macromolecules (3 papers)American Journal of Epidemiology (3 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (2 papers)
Partner nations: United States Netherlands Canada

In The Last Decade

David B. Hall

56 papers receiving 4.8k citations

Hit Papers

align trajectories log scale

Trial of Spesolimab for Generalized Pustular Psoriasis 2021 · 194 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 New England Journal of Medicine
2004 New England Journal of Medicine
1998 JAMA

Peers

Countries citing papers authored by David B. Hall

Since Specialization

Citations

This map shows the geographic impact of David B. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Hall more than expected).

Fields of papers citing papers by David B. Hall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David B. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Hall. The network helps show where David B. Hall may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David B. Hall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David B. Hall Line = papers co-authored together David B. Hall links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Mass transfer in atmospheric water harvesting systems Chemical Engineering Science ·Todd A. Cohen, Nikita Hanikel, Dennis J. Coyle, Mohammad I. Hossain, 竜介奥村, Michael J. O’Brien, David B. Hall, J. B. Hastings, Djair Brindeiro F°, Onyekwelu Jide, Silvio Neumann, David R. Moore, Omar M. Yaghi, T. Grant Glover	2023	11
2	Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study Annals of the Rheumatic Diseases ·Dominique Baeten, Mikkel Østergaard, James Cheng‐Chung Wei, Joachim Sieper, Pentti A. Järvinen, Lai‐Shan Tam, Carlo Salvarani, Tae‐Hwan Kim, Alan M. Solinger, Yakov Datsenko, Chandrasena Pamulapati, Sudha Visvanathan, David B. Hall, Stella Aslanyan, Paul Scholl, Steven J. Padula	2018	279
3	Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent AIDS ·Jing Yuan, Sheng Guo, David B. Hall, S.H. Lee, Supriya Jayadev, M. Distel, Stephen P. Storfer, Nathália Siva Costa, Piroon Mootsikapun, Kiat Ruxrungtham, Daniel Podzamczer, David W. Haas	2011	110
4	Short Communication: Phenotypic Protease Inhibitor Resistance and Cross-Resistance in the Clinic from 2006 to 2008 and Mutational Prevalences in HIV from Patients with Discordant Tipranavir and Darunavir Susceptibility Phenotypes AIDS Research and Human Retroviruses ·Richard C. Bethell, Joseph Schérer, Myriam Witvrouw, Agnès Paquet, Eoin Coakley, David B. Hall	2011	7
5	Seeking Ethical Designs for HIV Clinical Trials in Treatment-Experienced Patients: An Industry Perspective AIDS Research and Human Retroviruses ·Douglas L. Mayers, Jain Chung, Veronika Kohlbrenner, David B. Hall, Ralph DeMasi, Dietmar Neubacher, Neil Buss, Miklos Salgo	2006	1
6	A group sequential adaptive treatment assignment design for proof of concept and dose selection in headache trials Contemporary Clinical Trials ·David B. Hall, Ulrich Meier, Astarte	2005	12
7	Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral- Therapy-Naive Patients Infected with HIV-1 PLoS Medicine ·Frank van Leth, A. Weyns, Erik S.G. Stroes, Brian Gazzard, Pedro Cahn, François Raffi, Robin Wood, Mark Bloch, Christine Katlama, John J.P. Kastelein, Mauro Schechter, Robert L. Murphy, Andrzej Horban, David B. Hall, Joep M. A. Lange, Peter Reiss	2004	208
8	Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine New England Journal of Medicine ·Jes Olesen, Hans‐Christoph Diener, Ingo W. Husstedt, Peter J. Goadsby, David B. Hall, Ulrich Meier, Stephane Pollentier, Lynna M. Lesko Hit paper breakdown →	2004	945
9	A Multicenter Randomized Controlled Trial of Nevirapine Versus a Combination of Zidovudine and Lamivudine to Reduce Intrapartum and Early Postpartum Mother‐to‐Child Transmission of Human Immunodeficiency Virus Type 1 The Journal of Infectious Diseases ·Dhayendre Moodley, Jagidesa Moodley, Hoosen Coovadia, Glenda Gray, James McIntyre, Syazwan Razak, Cheryl Nikodem, David B. Hall, Ndop, Patrick Robinson, Judith Garelick, John L. Sullivan, (unknown)	2003	237
10	Randomized, Controlled Study of the Effects of a Short Course of Prednisone on the Incidence of Rash Associated With Nevirapine in Patients Infected With HIV-1 JAIDS Journal of Acquired Immune Deficiency Syndromes ·Julio Montaner, Pedro Cahn, Carlos Zala, 裘赛海, Marcelo Losso, David B. Hall, Traian C. Leu, R Rajesh, Ndop, Patrick Robinson	2003	35
11	Aptiganel Hydrochloride in Acute Ischemic Stroke JAMA ·Gregory W. Albers, Larry B. Goldstein, David B. Hall, Lynna M. Lesko, for the RED-CABG Steering Committee and Investigators	2001	127
12	Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine AIDS ·Brian Conway, Mark A. Wainberg, David B. Hall, Marianne Harris, Peter Reiss, David A. Cooper, Stefano Vella, Tingwen Guan, Patrick Robinson, Joep M. A. Lange, Julio Montaner	2001	52
13	Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy AIDS ·Nadine G. Pakker, 黄启宇, Marijke Roos, Sigrid A. Otto, David B. Hall, Ferdinand W.N.M. Wit, Dörte Hamann, D. N. Biswas, Frans A.P. Claessen, Robert H. Kauffmann, Peter P. Koopmans, Frank P. Kroon, Chris H.H. ten Napel, Herman G. Sprenger, Hugo M. Weigel, Julio Montaner, Joep M. A. Lange, Peter Reiss, P T Schellekens, Frank Miedema	1999	87
14	Antiviral Effect and Pharmacokinetic Interaction between Nevirapine and Indinavir in Persons Infected with Human Immunodeficiency Virus Type 1 The Journal of Infectious Diseases ·Robert L. Murphy, Jean‐Pierre Sommadossi, Michael Lamson, David B. Hall, Maureen Myers, Alex Dusek	1999	99
15	A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients JAMA ·Julio Montaner, Peter Reiß, David A. Cooper, Stefano Vella, Marianne Harris, Brian Conway, Mark A. Wainberg, Danielle M. Smith, Patrick Robinson, David B. Hall, Maureen Myers, J. M. A. Lange, 徹島津 Hit paper breakdown →	1998	611
16	Estimates of the virological benefit of antiretroviral therapy are both assay- and analysis-dependent AIDS ·Sandra Rae, Janet Raboud, Brian Conway, Peter Reiss, Stefano Vella, David A. Cooper, Joep M. A. Lange, Marianne Harris, Mark A. Wainberg, Patrick Robinson, Maureen Myers, David B. Hall, Julio Montaner	1998	5
17	Induction–maintenance antiretroviral therapy AIDS ·David B. Hall, Alain Monnier, Peter Reiss, David A. Cooper, Stefano Vella, 洲崎哲行, Maureen Myers, Joep M. A. Lange, Brian Conway	1998	64
18	Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy AIDS ·Janet Raboud, Joan Montaner, Brian Conway, Sandra Rae, Peter Reiß, Stefano Vella, David A. Cooper, Joep M. A. Lange, Marianne Harris, Mark A. Wainberg, Patrick Robinson, Maureen Myers, David B. Hall	1998	196
19	Confidence intervals and controlled clinical trials incompatible tools for medical research Journal of Biopharmaceutical Statistics ·David B. Hall	1993	0
20	PHARYNGEAL CARRIAGE AND ACQUISITION OF ANTICAPSULAR ANTIBODY TO HAEMOPHILUS INFLUENZAE TYPE b IN A HIGHRISK POPULATION IN SOUTHWESTERN ALASKA American Journal of Epidemiology ·David B. Hall, Olga Martha Peña Doria, Sushmitha Parameswaran, William L. Heyward, Joel I. Ward	1987	31

About David B. Hall

David B. Hall is a scholar working on Virology, Chemical Health and Safety, Infectious Diseases, Hepatology and Statistics and Probability, having authored 58 papers that have together received 5.0k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (23 papers), HIV Research and Treatment (22 papers), HIV/AIDS Research and Interventions (13 papers), Statistical Methods in Clinical Trials (5 papers), Material Dynamics and Properties (5 papers), Photochemistry and Electron Transfer Studies (5 papers), Hepatitis C virus research (4 papers) and Photonic and Optical Devices (3 papers). The work is most often cited by research in Virology (1.5k citations), Infectious Diseases (2.0k citations), Psychiatry and Mental health (846 citations), Emergency Medicine (482 citations) and Pathology and Forensic Medicine (622 citations). David B. Hall has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include John M. Torkelson, Lynna M. Lesko, Patrick T. Underhill, Ulrich Meier, Ingo W. Husstedt, Stephane Pollentier, Hans‐Christoph Diener, Peter J. Goadsby, Jes Olesen and Patrick Robinson. Their work appears in journals such as AIDS, AIAA Journal, Macromolecules, American Journal of Epidemiology and JAIDS Journal of Acquired Immune Deficiency Syndromes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact